SCHEDULE 13D

CUSIP No.

81726A209

1

Name of reporting person

Celadon Partners SPV 24

2

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

6

Citizenship or place of organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 9,777,000.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 9,777,000.00

11

Aggregate amount beneficially owned by each reporting person

9,777,000.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

13

Percent of class represented by amount in Row (11)

37.6 %

14

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13D

CUSIP No.

81726A209

1

Name of reporting person

Celadon Partners, LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

6

Citizenship or place of organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 9,777,000.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 9,777,000.00

11

Aggregate amount beneficially owned by each reporting person

9,777,000.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

13

Percent of class represented by amount in Row (11)

37.6 %

14

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13D

Item 1.

Security and Issuer

(a)

Title of Class of Securities:

Common Stock, par value $0.0001

(b)

Name of Issuer:

Senti Biosciences, Inc.

(c)

Address of Issuer's Principal Executive Offices:

2 Corporate Drive, First Floor, South San Francisco, CALIFORNIA , 94080.

Item 1 Comment:

This Amendment No. 1 ("Amendment No. 1") to Schedule 13D amends the Schedule 13D originally filed on March 13, 2025 (the "Schedule 13D") relating to the Common Stock of the Issuer. Unless otherwise defined herein, all capitalized terms used herein shall have the meanings given to them in the Schedule 13D. This Amendment No. 1 is being filed solely to provide Appendix A referenced in Item 2(d) of the Schedule 13D. No other information is being amended.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Celadon Partners SPV 24

Signature:	/s/ David Egglishaw
Name/Title:	David Egglishaw, Manager, Celadon Partners, LLC (as sole manager of Celadon Partners SPV 24)
Date:	03/17/2025

Celadon Partners, LLC

Signature:	/s/ David Egglishaw
Name/Title:	David Egglishaw, Manager
Date:	03/17/2025